Search results
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets
Investor's Business Daily· 1 year agoShares of TG Therapeutics soared Monday after the company more than doubled Wall Street's...
TG Therapeutics' (NASDAQ:TGTX) investors will be pleased with their 26% return over the last five...
Simply Wall St. via Yahoo Finance· 1 year agoWhen you buy and hold a stock for the long term, you definitely want it to provide a positive...
TG Therapeutics Reverses Its 225% Winning Streak On Lackluster Guidance
Investor's Business Daily· 4 months agoSales of a new multiple sclerosis drug from TG Therapeutics crushed analysts' expectations, but TGTX...
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
Investor's Business Daily· 10 months agoRoche unveiled positive results Thursday for a rival to TG Therapeutics' one-hour infusion for...
TG Therapeutics (TGTX) Gets FDA Nod for Multiple Sclerosis Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves TG Therapeutics' (TGTX) Briumvi (ublituximab-xiiy) for treating relapsing forms of...
Biotech Growth Stock Boosted By FDA Approval For Multiple Sclerosis Treatment
Investor's Business Daily· 1 year agoBiotech growth stock TG Therapeutics got FDA approval for its multiple sclerosis drug in December,...
Why Shares of TG Therapeutics Soared on Tuesday
Motley Fool· 1 year agoWhat happened Shares of TG Therapeutics (NASDAQ: TGTX) were up by 18% as of mid-afternoon Tuesday after reports that the biotech's multiple sclerosis...
2 Biotech Stocks Under $10 That Could Win From Key FDA Approvals
TipRanks via Yahoo Finance· 1 year agoThe biotech industry can bring investors some truly lucrative gains – but these stocks are not for...
Pfizer Makes Progress, but This Biotech Was Wednesday's Big Winner
Motley Fool· 1 year agoThe stock market seems bound and determined to leave investors with bad memories of 2022, with major...
Company News for Dec 30, 2022
Zacks via Yahoo Finance· 1 year agoImmunoGen, Inc.’s IMGN shares jumped 5.5% after it announced CFO Susan Altschuller would not return from her time off. Shares of TG Therapeutics, Inc....
